The Food and Drug Administration granted 40 orthopedic- and spine-related clearances in May.
June 07, 2013
The Food and Drug Administration granted 15 spine-related medical device clearances in May.
Blue Belt Technologies received 510(k) clearance from the U.S. Food and Drug Administration for its STRIDE Unicondylar Knee implant.
The FDA has accepted BioMarin Pharmaceutical's biologics license application for Vimizim, an enzyme therapy that could be used to treat Mucopolysaccharidosis Type IVA or Morquio A Syndrome, according to Pipeline Review.
The Orthopedic and Rehabilitation panel for the U.S. Food and Drug Administration recommended changes to the pedicle screw's classification when it's used for treating degenerative disc disease and spondylolisthesis, according to a Medscape report.
Spinal Elements, based in Carlsbad, Calif., has licensed a portfolio of patents for accessing the lumbar spine and placing implants from a lateral approach.
Santa Clara, Calif.-based Benvenue Medical completed the yearlong patient follow-up phase in the clinical trial of its Kiva vertebral compression fracture treatment.
The Food and Drug Administration granted 35 orthopedic- and spine-focused 510(k) clearances in April.
New York City-based Paradigm Spine launched its coflex Solution website, a patient-centered site with information on lumbar spinal stenosis and both surgical and non-surgical treatment options.
On May 7, Behrooz Akbarnia, MD, led a team of surgeons at Rady Children's Hospital-San Diego in performing two pediatric surgeries with Ellipse Technologies' MAGnetic Expansion Control System.
Published in Spine